文献速递血脂与心血管预防

低总胆固醇与未服他汀的70岁以上男性主要不良心血管事件增加相关

Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins.
PubMed 文献 · Heart · 2019-10-13

CHAMP前瞻性队列纳入1289名70岁以上无缺血性心脏病男性,平均随访6.4年。未服他汀者总胆固醇每降低1 mmol/L,主要不良心血管事件风险增加27%(HR 1.27,95%CI 1.10–1.45),服他汀者无此关联。

要点

  • 70岁以上无缺血性心脏病男性中,低总胆固醇与主要不良心血管事件风险增加相关。
  • 该关联仅见于未服他汀者,服他汀者低总胆固醇未显示风险增加。
  • 低总胆固醇可能反映衰弱与共病负担,而非独立致病因素。

核心结论

  • 在无缺血性心脏病的70岁以上男性中,低总胆固醇与主要不良心血管事件风险增加相关,但该关联仅限于未服他汀者。

研究设计与样本

  • CHAMP为社区居住70岁以上男性的前瞻性队列研究,共纳入1289名男性,平均年龄77.0±5.5岁,平均随访6.4±2.7年。
  • 采用Cox回归模型分析总胆固醇与长期主要不良心血管事件的关系,校正共病并按他汀使用分层。

主要发现

  • 总胆固醇水平降低与共病负担增加、衰弱及主要不良心血管事件增加呈线性趋势(p<0.001)。
  • 未服他汀者(n=731)总胆固醇每降低1 mmol/L,主要不良心血管事件风险增加(HR 1.27,95%CI 1.10–1.45,p=0.001),死亡风险增加(HR 1.22,95%CI 1.03–1.44,p=0.02)。
  • 服他汀者(n=558)低总胆固醇与主要不良心血管事件(HR 0.91,95%CI 0.74–1.11)及死亡(HR 0.86,95%CI 0.68–1.09)无显著关联。

临床怎么用

  • 对未服他汀的70岁以上男性,低总胆固醇应提示评估共病与衰弱状态,而非仅视为血脂达标。
  • 服他汀的老年男性中,低总胆固醇未显示与主要不良心血管事件风险增加相关。

局限性

  • 研究人群为社区居住的70岁以上男性,结论外推至女性或其他年龄段需谨慎。
  • 观察性设计无法完全排除残余混杂,低总胆固醇可能为衰弱与共病的标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Low levels of total cholesterol (TC) are associated with adverse outcomes in older populations. Whether this phenomenon is independent of statin use is unknown. We investigated the association between low TC levels and long-term major adverse cardiovascular events (MACE) in a prospective study of men aged ≥70 years without ischaemic heart disease (IHD) and whether this was influenced by statin use. METHODS: The CHAMP (Concord Health and Ageing in Men Project) cohort is a prospective cohort study of community-dwelling men aged ≥70 years. The relationship between TC and long-term MACE was analysed using Cox-regression modelling adjusted for comorbidities and stratified by statin use. RESULTS: The study cohort comprised 1289 men (mean (±SD) age, 77.0±5.5 years; mean follow-up, 6.4±2.7 years). Decreasing TC level was associated with increased comorbidity burden, frailty and MACE (linear trend p<0.001). In men not on statin therapy (n=731), each 1 mmol/L decrease in TC was associated with increased MACE (HR 1.27, 95% CI 1.10 to 1.45, p=0.001) and mortality (HR 1.22, 95% CI 1.03 to 1.44, p=0.02) adjusted for comorbidities. In contrast, low TC in men on statins (n=558) was not associated with MACE (HR 0.91, 95% CI 0.74 to 1.11) or mortality (HR 0.86, 95% CI 0.68 to 1.09). CONCLUSION: Low TC is associated with increased risk of MACE in older men without IHD who are not taking statin therapy but not in those on statins.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Gnanenthiran SR, Ng ACC, Cumming R, et al. Low total cholesterol is associated with increased major adverse cardiovascular events in men aged ≥70 years not taking statins. Heart. 2019. PMID: 31611326. doi:10.1136/heartjnl-2019-315449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。